Keyphrases
Community-acquired Pneumonia
100%
Insulin Resistance
95%
COVID-19
85%
Randomized Controlled Trial
72%
Interleukin-6
70%
Oral Glucose Tolerance Test
67%
Prospective Cohort Study
61%
Type 2 Diabetes Mellitus (T2DM)
53%
HIV Patients
50%
Physical Activity
47%
Diabetes
44%
Obesity
39%
Insulin
39%
Body Composition
38%
High-intensity Interval Training
36%
Western Tanzania
36%
Type 2 Diabetic Patients
35%
Tumor Necrosis Factor-α
34%
Incretin Effect
34%
Exercise Effect
33%
Physical Activity Level
31%
Hospitalization
31%
Hemoglobin A1c (HbA1c)
31%
Bed Rest
30%
Hyperglycemia
29%
Glucose Metabolism
27%
Exercise Training
27%
Cell Dysfunction
26%
Cystic Fibrosis
26%
Visceral Adipose Tissue
26%
Cardiac Structure
26%
Cardiac Function
26%
Glucagon
25%
Body Mass Index
24%
Tanzania
24%
During Exercise
24%
Tocilizumab
23%
Abdominal Obesity
23%
Fat Mass
23%
Cardiorespiratory Fitness
22%
Insulin Sensitivity
22%
Antiretroviral Therapy
22%
Glucagon-like
22%
Adiponectin
22%
Undernutrition
20%
Physical Capacity
20%
Continuous Positive Airway Pressure
20%
Confidence Interval
20%
Mortality Risk
20%
Plasma Glucose
20%
Medicine and Dentistry
Community-Acquired Pneumonia
91%
Diabetes
82%
Cross Sectional Study
73%
Insulin Resistance
72%
COVID-19
63%
Oral Glucose Tolerance Test
53%
Randomized Controlled Trial
52%
Prospective Cohort Study
52%
Human Immunodeficiency Virus
46%
Exercise
44%
Maturity Onset Diabetes of the Young
42%
Physical Activity
38%
Interleukin 6
38%
Insulin Sensitivity
37%
Adipose Tissue
36%
Cystic Fibrosis
34%
Hemoglobin A1c
26%
Impaired Glucose Tolerance
24%
Insulin Release
24%
Hyperglycemia
23%
Glucose Tolerance
22%
Body Mass Index
22%
Quality of Life
22%
Infection
21%
Glucagon
21%
Cell Function
21%
Cardiorespiratory
20%
C Reactive Protein
20%
Incretin
20%
Patient with Type 2 Diabetes
19%
Malnutrition
19%
Glucose Metabolism
19%
Bed Rest
18%
High Intensity Interval Training
18%
Randomized Clinical Trial
18%
Homeostatic Model Assessment
17%
Aerobic Exercise
17%
Continuous Positive Airway Pressure
17%
Stomach Emptying
17%
Chronic Obstructive Pulmonary Disease
17%
Disease
16%
Secretion (Process)
15%
Cognition
15%
Tocilizumab
14%
Antiretroviral Therapy
14%
Proinsulin
14%
Abdominal Obesity
14%
Skeletal Muscle
14%
Tumor Necrosis Factor
13%
Glycemic
13%
Nursing and Health Professions
Community Acquired Pneumonia
52%
Human Immunodeficiency Virus
43%
Oral Glucose Tolerance Test
40%
Hospital Readmission
37%
Body Composition
36%
Insulin Resistance
33%
Glucose Blood Level
32%
Non Insulin Dependent Diabetes Mellitus
29%
Disease
28%
Cross-Sectional Study
28%
Interleukin 6
28%
Tumor Necrosis Factor
28%
High-Intensity Interval Training
27%
Continuous Positive Airway Pressure
26%
Prospective Cohort Study
26%
Incretin
26%
Cystic Fibrosis
26%
Body Mass
25%
Patient with Type 2 Diabetes
23%
Glucose Tolerance
22%
Confidence Interval
20%
Antiretroviral Therapy
20%
Impaired Glucose Tolerance
19%
Abdominal Obesity
18%
Fat Mass
18%
Inflammation
17%
Hyperglycemia
17%
Glucose Infusion
15%
Hemoglobin A1c
14%
Glucagon
14%
Heart Left Ventricle Mass
14%
Grip Strength
14%
Quality of Life
14%
Infusion
14%
Hypoglycemia
13%
Fat Free Mass
13%
Nuclear Magnetic Resonance Imaging
13%
Placebo
13%
Prevalence
13%
Functional Status
13%
Glucagon Like Peptide 1
13%
Blood Level
12%
Oxygenation
12%
Stable Isotope
12%
Obesity
12%
Dual Energy X Ray Absorptiometry
12%
Caloric Intake
12%
Length of Stay
11%
Infusion Rate
11%
Step Count
11%
